Sharita Williams

By /

EVALUATION OF NASOPHARYNGEAL CARCINOMA CELLS TREATED WITH REPEATED DOSING OF EPIGALLOCATECHIN-3-GALLATE, THYMOQUINONE, OR 5 – FLUOROURACIL

Scroll to Top